Sanofi India Limited (SANOFI) Share Price
NSE · Healthcare · Drug Manufacturers - General · ISIN INE058A01010
Key metrics
- Market Cap
- ₹7,345 Cr
- P/E Ratio
- 22.46
- EPS
- 140.5
- Book Value
- 325.31
- P/B Ratio
- 9.8
- ROE
- 43.61%
- ROCE
- 59.19%
- Debt / Equity
- 0.02
- Net Margin
- 17.92%
- Revenue Growth
- -8.33%
- Profit Growth
- -20.99%
- Dividend Yield
- 7.6%
- 52W High
- ₹5,175.50
- 52W Low
- ₹3,054.00
- Market Cap Band
- mid cap
- Face Value
- 10
Ratios computed from the annual results period ending 2025-12-31.
About Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.
- Headquarters
- Mumbai, India
- Employees
- 1,097
- Promoter Holding
- 60.6%
The full Sanofi India Limited analysis
Create a free account to open the complete SANOFI deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.